Laura Waters

6.2k total citations · 2 hit papers
96 papers, 2.2k citations indexed

About

Laura Waters is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Laura Waters has authored 96 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 39 papers in Virology and 24 papers in Emergency Medicine. Recurrent topics in Laura Waters's work include HIV/AIDS drug development and treatment (53 papers), HIV/AIDS Research and Interventions (41 papers) and HIV Research and Treatment (37 papers). Laura Waters is often cited by papers focused on HIV/AIDS drug development and treatment (53 papers), HIV/AIDS Research and Interventions (41 papers) and HIV Research and Treatment (37 papers). Laura Waters collaborates with scholars based in United Kingdom, United States and Italy. Laura Waters's co-authors include Mark Nelson, Sundhiya Mandalia, Brian Gazzard, Marta Boffito, Frank A. Post, Chloe Orkin, Anton Pozniak, Stefan Eßer, Jürgen K. Rockstroh and Paul E. Sax and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Laura Waters

88 papers receiving 2.1k citations

Hit Papers

Weight Gain Following Initiation of Antiretroviral Therap... 2019 2026 2021 2023 2019 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
    2019 468 citations Chloe Orkin, Stefan Eßer et al. Clinical Infectious Diseases profile →
  2. Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
    2022 162 citations Anton Pozniak, Marta Boffito et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Waters United Kingdom 25 1.6k 936 798 472 133 96 2.2k
Cristina Gervasoni Italy 22 1.4k 0.9× 601 0.6× 619 0.8× 578 1.2× 83 0.6× 132 2.1k
Antonio Di Biagio Italy 26 1.7k 1.1× 984 1.1× 709 0.9× 695 1.5× 224 1.7× 263 2.8k
Markus Bickel Germany 25 1.1k 0.7× 657 0.7× 638 0.8× 691 1.5× 119 0.9× 73 1.9k
Camlin Tierney United States 21 1.7k 1.1× 1.2k 1.2× 899 1.1× 383 0.8× 115 0.9× 60 2.4k
Peter F. Rebeiro United States 26 1.8k 1.1× 665 0.7× 843 1.1× 929 2.0× 57 0.4× 119 2.3k
Michael F. Para United States 21 1.3k 0.8× 1.0k 1.1× 411 0.5× 531 1.1× 128 1.0× 55 2.0k
Catherine Godfrey United States 25 1.8k 1.1× 1.3k 1.4× 651 0.8× 752 1.6× 187 1.4× 80 2.8k
Michael P. Dubé United States 33 1.9k 1.2× 1.2k 1.2× 1.5k 1.8× 926 2.0× 171 1.3× 96 3.2k
Susan L. Rosenkranz United States 21 993 0.6× 684 0.7× 437 0.5× 258 0.5× 73 0.5× 52 1.9k
Paula Munderi Uganda 24 1.4k 0.9× 611 0.7× 512 0.6× 655 1.4× 45 0.3× 95 2.0k

Countries citing papers authored by Laura Waters

Since Specialization
Citations

This map shows the geographic impact of Laura Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Waters more than expected).

Fields of papers citing papers by Laura Waters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Waters. The network helps show where Laura Waters may publish in the future.

Co-authorship network of co-authors of Laura Waters

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Waters. A scholar is included among the top collaborators of Laura Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Waters. Laura Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Smuk, Melanie, Sara Paparini, Vanessa Apea, et al.. (2024). Cross-sectional survey of sexual health professionals’ experiences and perceptions of the 2022 mpox outbreak in the UK. BMJ Open. 14(1). e080250–e080250. 7 indexed citations
4.
Waters, Laura, Yusuf Hassan Wada, & Tristan Barber. (2023). InternationalAIDSsociety conference 2023 summary. HIV Medicine. 25(2). 168–173. 1 indexed citations
5.
Alrubayyi, Aljawharah, Emma Touizer, Ester Gea‐Mallorquí, et al.. (2023). Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1. Scientific Reports. 13(1). 18994–18994. 6 indexed citations
6.
Cresswell, Fiona V, Sanjay Bhagani, Marta Boffito, et al.. (2022). UK guideline for the use of HIV post‐exposure prophylaxis 2021. HIV Medicine. 23(5). 494–545. 18 indexed citations
7.
8.
Brown, Alison, Sara Croxford, Sophie Nash, et al.. (2021). COVID‐19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID‐19 pandemic in England. HIV Medicine. 23(1). 90–102. 13 indexed citations
9.
Ibrahim, Fowzia, Lucy Campbell, Sarah Stockwell, et al.. (2020). Estimated glomerular filtration rate slopes on tenofovir alafenamide. HIV Medicine. 21(9). 607–612. 11 indexed citations
10.
Figueroa, José Natal, Laura Waters, Sara Croxford, et al.. (2019). HIV care cost in England: a cross‐sectional analysis of antiretroviral treatment and the impact of generic introduction. HIV Medicine. 20(6). 377–391. 8 indexed citations
11.
Boffito, Marta, Laura Waters, Pedro Cahn, et al.. (2019). Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection. AIDS Research and Human Retroviruses. 36(1). 13–18. 28 indexed citations
12.
Gupta, Rakesh, Sultan Abdul-Jawad, Laura E. McCoy, et al.. (2019). Sustained HIV-1 remission following CCR5D32/D32 allogeneic haematopoietic stem cell transplantation. HIV Medicine. 20. 8–8. 2 indexed citations
13.
Gatell, José M., Lambert Assoumou, Graeme Moyle, et al.. (2017). Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk. AIDS. 31(18). 2503–2514. 54 indexed citations
14.
Lewis, Joseph M., Colette Smith, Shazaad Ahmad, et al.. (2017). Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study. Journal of Infection. 74(4). 401–407. 11 indexed citations
15.
16.
King, Marco‐Felipe, Catherine J. Noakes, Andrew Sleigh, S. Bale, & Laura Waters. (2016). Relationship between healthcare worker surface contacts, care type and hand hygiene: an observational study in a single-bed hospital ward. Journal of Hospital Infection. 94(1). 48–51. 13 indexed citations
17.
Ferns, R. Bridget, Miao He, Roberto Rigatti, et al.. (2015). Ultra-deep sequencing provides insights into the virology of hepatitis C super-infections in a case of three sequential infections with different genotypes. Journal of Clinical Virology. 70. 63–66. 5 indexed citations
18.
Dickinson, Laura, Marta Boffito, D.J. Back, et al.. (2009). Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. Journal of Antimicrobial Chemotherapy. 63(6). 1233–1243. 28 indexed citations
19.
Waters, Laura & Mark Nelson. (2007). The use of caspofungin in HIV-infected individuals. Expert Opinion on Investigational Drugs. 16(6). 899–908. 11 indexed citations
20.
Waters, Laura. (2004). A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts. Journal of Antimicrobial Chemotherapy. 54(2). 503–507. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Gervasoni Breakdown of academic impact, for papers by Antonio Di Biagio Breakdown of academic impact, for papers by Markus Bickel Breakdown of academic impact, for papers by Camlin Tierney Breakdown of academic impact, for papers by Peter F. Rebeiro Breakdown of academic impact, for papers by Michael F. Para Breakdown of academic impact, for papers by Catherine Godfrey Breakdown of academic impact, for papers by Michael P. Dubé Breakdown of academic impact, for papers by Susan L. Rosenkranz Breakdown of academic impact, for papers by Paula Munderi
Rankless by CCL
2026